Cargando…
An investigation of microRNA‐103 and microRNA‐107 as potential blood‐based biomarkers for disease risk and progression of Alzheimer's disease
BACKGROUND: This study aimed to assess the correlation of circulating microRNA‐103 (miR‐103) and microRNA‐107 (miR‐107) with disease risk and cognitive impairment of Alzheimer's disease (AD). METHODS: Plasma samples from 120 AD patients, 120 Parkinson's disease (PD) patients (served as dis...
Autores principales: | Wang, Jie, Chen, Chunyan, Zhang, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977154/ https://www.ncbi.nlm.nih.gov/pubmed/31420923 http://dx.doi.org/10.1002/jcla.23006 |
Ejemplares similares
-
MicroRNAs-103/107 coordinately regulate macropinocytosis and autophagy
por: Park, Jong Kook, et al.
Publicado: (2016) -
Decreased microRNA 103 and microRNA 107 predict increased risks of acute respiratory distress syndrome and 28-day mortality in sepsis patients
por: Wang, Qianqian, et al.
Publicado: (2020) -
microRNA-Based Biomarkers and the Diagnosis of Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2015) -
microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2020) -
MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer
por: Li, Xiaohua, et al.
Publicado: (2011)